Skip to main content
Top
Published in: Endocrine 2/2013

01-10-2013 | Original Article

Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma

Authors: Gianluca Iacobellis, Luigi Petramala, Giuseppe Barbaro, Atil Y. Kargi, Valentina Serra, Laura Zinnamosca, Luciano Colangelo, Cristiano Marinelli, Antonio Ciardi, Giorgio De Toma, Claudio Letizia

Published in: Endocrine | Issue 2/2013

Login to get access

Abstract

Emerging evidences indicate that patients diagnosed with adrenal incidentaloma may present with cardiovascular complications. Epicardial fat is known to play a role in left ventricle (LV) changes. Whether epicardial fat can be associated with LV mass (LVM) in patients with incidentaloma is unknown. We test the hypothesis that echocardiographic epicardial fat thickness is independently related to LVM in a well-studied group of subjects with adrenal incidentaloma. 46 consecutive patients (age 59 ± 9 years) with imaging diagnosis of adrenal incidentaloma and 30 healthy controls underwent echocardiogram for epicardial fat thickness and LVM measurement. Non-functional incidentaloma was confirmed in 40 subjects, whereas 6 patients were actually diagnosed with mild Cushing’s syndrome. Epicardial fat thickness was significantly higher in patients with incidentaloma and mild Cushing’s syndrome when compared to controls, (p < 0.01 for both). LVMh2.7 was higher in subjects with adrenal incidentaloma than in controls and higher in subjects with mild Cushing’s syndrome than in those with adrenal incidentaloma (p < 0.05 and p < 0.01). Multiple regression analysis showed that epicardial fat thickness was the best correlate (R 2 = 0.36, β 2.8, p < 0.01) of LVM in overall study patients. We showed for the first time that (1) epicardial fat thickness and LVM are higher in subjects with adrenal incidentaloma and (2) epicardial fat thickness independently correlates with LVM. Echocardiographic epicardial fat may serve as non-invasive marker of visceral fat and earlier cardiac abnormalities in patients with adrenal incidentaloma.
Literature
1.
go back to reference C. Davenport, A. Liew, B. Doherty, H.H. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80–83 (2011)PubMedCrossRef C. Davenport, A. Liew, B. Doherty, H.H. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80–83 (2011)PubMedCrossRef
2.
go back to reference F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Alì, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)PubMedCrossRef F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Alì, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)PubMedCrossRef
3.
go back to reference R. Rossi, L. Tauchmanova, A. Di Luciano, M. Martino, C. Battista, L. Del Viscovo, V. Nuzzo, G. Lombardi, Mild Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab. 85, 1440–1448 (2000)PubMedCrossRef R. Rossi, L. Tauchmanova, A. Di Luciano, M. Martino, C. Battista, L. Del Viscovo, V. Nuzzo, G. Lombardi, Mild Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab. 85, 1440–1448 (2000)PubMedCrossRef
4.
go back to reference M. Terzolo, G. Osella, A. Alì, G. Borretta, F. Cesario, P. Paccotti, A. Angeli, Mild Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48, 89–97 (1998)CrossRef M. Terzolo, G. Osella, A. Alì, G. Borretta, F. Cesario, P. Paccotti, A. Angeli, Mild Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48, 89–97 (1998)CrossRef
5.
go back to reference D.A. Vassiliadi, S. Tsagarakis, Subclinical hypercortisolism: debatable or visible on the lightbox? Endocrine 42, 7–8 (2012)PubMedCrossRef D.A. Vassiliadi, S. Tsagarakis, Subclinical hypercortisolism: debatable or visible on the lightbox? Endocrine 42, 7–8 (2012)PubMedCrossRef
6.
go back to reference R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41, 415–423 (2012)PubMedCrossRef R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41, 415–423 (2012)PubMedCrossRef
7.
go back to reference F. Ermetici, C. Dall’Asta, A.E. Malavazos, L. Morricone, C. Dall’Asta, M.M. Corsi, B. Ambrosi, Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J. Endocrinol. Invest. 31, 573–577 (2008)PubMed F. Ermetici, C. Dall’Asta, A.E. Malavazos, L. Morricone, C. Dall’Asta, M.M. Corsi, B. Ambrosi, Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J. Endocrinol. Invest. 31, 573–577 (2008)PubMed
8.
go back to reference G. Iacobellis, D. Corradi, A.M. Sharma, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat. Clin. Pract. Cardiovasc. Med. 2, 536–543 (2005)PubMedCrossRef G. Iacobellis, D. Corradi, A.M. Sharma, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat. Clin. Pract. Cardiovasc. Med. 2, 536–543 (2005)PubMedCrossRef
9.
go back to reference G. Iacobellis, A.C. Bianco, Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol. Metab. 22, 450–457 (2011)PubMedCrossRef G. Iacobellis, A.C. Bianco, Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol. Metab. 22, 450–457 (2011)PubMedCrossRef
10.
go back to reference G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C.V. Iannucci, F. Leonetti, Relation between epicardial adipose tissue and left ventricular mass. Am. J. Cardiol. 94, 1084–1087 (2004)PubMedCrossRef G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C.V. Iannucci, F. Leonetti, Relation between epicardial adipose tissue and left ventricular mass. Am. J. Cardiol. 94, 1084–1087 (2004)PubMedCrossRef
11.
go back to reference G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 388, 5163–5168 (2003)CrossRef G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 388, 5163–5168 (2003)CrossRef
12.
go back to reference G. Iacobellis, H.J. Willens, Echocardiographic epicardial fat: a review of research and clinical applications. J. Am. Soc. Echocardiogr. 22, 1311–1319 (2009)PubMedCrossRef G. Iacobellis, H.J. Willens, Echocardiographic epicardial fat: a review of research and clinical applications. J. Am. Soc. Echocardiogr. 22, 1311–1319 (2009)PubMedCrossRef
13.
go back to reference L.K. Nieman, Approach to the patient with an adrenal incidentaloma. J. Clin. Endocrinol. Metab. 95, 4106–4113 (2010)PubMedCrossRef L.K. Nieman, Approach to the patient with an adrenal incidentaloma. J. Clin. Endocrinol. Metab. 95, 4106–4113 (2010)PubMedCrossRef
14.
go back to reference S. Bujawansa, D. Bowen-Jones, Low investigation rate for adrenal incidentalomas. Endocrine 40, 134–136 (2011)PubMedCrossRef S. Bujawansa, D. Bowen-Jones, Low investigation rate for adrenal incidentalomas. Endocrine 40, 134–136 (2011)PubMedCrossRef
15.
go back to reference A.E. Malavazos, G. Di Leo, F. Secchi, E.N. Lupo, G. Dogliotti, C. Coman, L. Morricone, M.M. Corsi, F. Sardanelli, G. Iacobellis, Relation of echocardiographic epicardial fat thickness and myocardial fat. Am. J. Cardiol. 105, 1831–1835 (2010)PubMedCrossRef A.E. Malavazos, G. Di Leo, F. Secchi, E.N. Lupo, G. Dogliotti, C. Coman, L. Morricone, M.M. Corsi, F. Sardanelli, G. Iacobellis, Relation of echocardiographic epicardial fat thickness and myocardial fat. Am. J. Cardiol. 105, 1831–1835 (2010)PubMedCrossRef
Metadata
Title
Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma
Authors
Gianluca Iacobellis
Luigi Petramala
Giuseppe Barbaro
Atil Y. Kargi
Valentina Serra
Laura Zinnamosca
Luciano Colangelo
Cristiano Marinelli
Antonio Ciardi
Giorgio De Toma
Claudio Letizia
Publication date
01-10-2013
Publisher
Springer US
Published in
Endocrine / Issue 2/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-9902-5

Other articles of this Issue 2/2013

Endocrine 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.